SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
556Isotechnika successfully extends trial of ISA247 2006-10-05 09:24 ET - News Relteevee-10/5/2006
555New Phase III Data Show Abbott's HUMIRA(R) (Adalimumab) Was Statistically Sunigel bates-10/5/2006
554Orphan nuclear receptor directs differentiation of proinflammatory cells Last Ukeokalani'nui-9/22/2006
553NicOx gives full details of naproxcinod phase 3 plan in osteoarthritis and an upnigel bates-9/6/2006
552Matrilin-3 Gene Discovered To Prevent Onset Of Osteoarthritis Main Category: ArtLJM-7/27/2006
551The Role of Soap in Acne Posted 07/11/2006 Craig G Burkhart, MD, MPH In clinicIan@SI-7/19/2006
550MiniReview of drugs under development for IBD: >>Mini Rev Med Chem. 2006 tuck-7/19/2006
549ZymoGenetics and Serono Present Positive Results of TACI-Ig Phase 1b Trial in Rhnigel bates-6/26/2006
548Analysis: Arthritis market to hit $10B WASHINGTON, DC, United States (UPI) -- AIcebrg-6/13/2006
547New Study Shows Novel Therapy May Produce Early Remission In Crohn's PatientLJM-5/23/2006
546Debiopharm and TcLand Sign R&D and Exclusive License Option for the Developmnigel bates-5/22/2006
545Chelsea Therapeutics and Active Biotech to Co-Develop Portfolio of Therapeutics nigel bates-5/9/2006
544The Promise Of A B-cell Biologic Therapy For Rheumatoid Arthritis Main CategorLJM-5/1/2006
543Genetic Finding Suggests Alternative Treatment Strategy For Common, Complex SkinLJM-4/29/2006
542UCB Submits Marketing Authorisation Application in Europe for CIMZIATM, a New Crnigel bates-4/28/2006
541<i>This is an exciting program. Here is the abstract from the 2005 meetinkeokalani'nui-4/27/2006
540Chugai Announces Japanese Phase III Trial Data Demonstrates Efficacy of 'Actnigel bates-4/26/2006
539Study Confirms Predictive Utility of Ibex Arthritis Biomarker Assays in Rheumatonigel bates-4/25/2006
538Biogen Idec sells psoriasis drug as it restructures Boston Business Journal - 9:Icebrg-4/4/2006
537U-M Scientists Identify Major Psoriasis Susceptibility Gene Source: University sim1-3/16/2006
536>>IC747 Icos Corp. oral LFA-1 inhibitor II psoriasis >> Has alreadyIcebrg-3/16/2006
535Treatments in development for psoriasis and/or psoriatic arthritis First createsoftware salesperson-3/15/2006
534Never looked at this program before. Might have to check out the event (headachekeokalani'nui-3/6/2006
533<i>The Lancet study also suggests the anti-impotence drug Viagra may help Ian@SI-2/24/2006
532Fresh theory on cause of Crohn's A weakened immune system - not an over-actIcebrg-2/24/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News